WASHINGTON - President Clinton's proposed federal budget for fiscal year 1994 increases support for biotechnology programs in many agencies intended to boost applied research and the competitiveness of the industry, but cuts basic research programs and CRADA funding at the NIH.

In the budget submitted last week, the FDA would receive 14 percent less federal funding in the fiscal year beginning next October, thus contributing to deficit-reduction efforts. But the reduction is more than offset by the $54 million in user fee revenues that the FDA plans to collect from prescription drug companies in 1994, and the $200 million in user fees it plans to charge non-prescription drug, medical device and food companies.